Commerce Bank Raises Stock Holdings in Encompass Health Co. (NYSE:EHC)

Commerce Bank lifted its holdings in shares of Encompass Health Co. (NYSE:EHC) by 2.6% during the third quarter, HoldingsChannel.com reports. The fund owned 7,835 shares of the company’s stock after purchasing an additional 200 shares during the quarter. Commerce Bank’s holdings in Encompass Health were worth $757,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also modified their holdings of the business. UMB Bank n.a. grew its position in Encompass Health by 387.7% during the 3rd quarter. UMB Bank n.a. now owns 317 shares of the company’s stock worth $31,000 after purchasing an additional 252 shares during the last quarter. V Square Quantitative Management LLC grew its holdings in shares of Encompass Health by 53.0% during the third quarter. V Square Quantitative Management LLC now owns 404 shares of the company’s stock worth $39,000 after buying an additional 140 shares during the last quarter. Oakworth Capital Inc. acquired a new position in Encompass Health in the 2nd quarter valued at about $40,000. Avior Wealth Management LLC purchased a new stake in Encompass Health during the 3rd quarter valued at approximately $40,000. Finally, Benjamin F. Edwards & Company Inc. lifted its position in Encompass Health by 58.9% during the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 534 shares of the company’s stock worth $46,000 after acquiring an additional 198 shares during the period. 97.25% of the stock is owned by institutional investors and hedge funds.

Encompass Health Trading Up 0.9 %

Shares of Encompass Health stock opened at $102.00 on Tuesday. The company has a 50-day moving average of $97.28 and a two-hundred day moving average of $90.99. The stock has a market cap of $10.28 billion, a PE ratio of 24.64, a price-to-earnings-growth ratio of 1.34 and a beta of 0.88. The company has a current ratio of 1.04, a quick ratio of 1.04 and a debt-to-equity ratio of 0.88. Encompass Health Co. has a 12-month low of $63.78 and a 12-month high of $104.55.

Encompass Health (NYSE:EHC) last issued its quarterly earnings data on Monday, October 28th. The company reported $1.03 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.94 by $0.09. The firm had revenue of $1.35 billion during the quarter, compared to analysts’ expectations of $1.33 billion. Encompass Health had a return on equity of 17.60% and a net margin of 8.10%. Encompass Health’s revenue was up 11.9% on a year-over-year basis. During the same period in the previous year, the firm posted $0.86 earnings per share. On average, research analysts anticipate that Encompass Health Co. will post 4.29 EPS for the current fiscal year.

Encompass Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 15th. Investors of record on Thursday, January 2nd will be paid a $0.17 dividend. The ex-dividend date of this dividend is Thursday, January 2nd. This represents a $0.68 dividend on an annualized basis and a yield of 0.67%. Encompass Health’s payout ratio is 16.43%.

Analyst Ratings Changes

EHC has been the topic of a number of recent research reports. Stephens reissued an “overweight” rating and issued a $105.00 target price on shares of Encompass Health in a report on Tuesday, August 6th. Barclays upped their price objective on shares of Encompass Health from $109.00 to $116.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 29th. Truist Financial reaffirmed a “buy” rating and issued a $116.00 target price (up previously from $108.00) on shares of Encompass Health in a report on Wednesday, October 30th. UBS Group increased their price target on shares of Encompass Health from $100.00 to $110.00 and gave the stock a “buy” rating in a report on Wednesday, September 25th. Finally, KeyCorp lifted their price objective on Encompass Health from $115.00 to $117.00 and gave the company an “overweight” rating in a report on Tuesday, October 29th. Nine equities research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Buy” and a consensus target price of $107.11.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.